Sonova Beats Profit Forecasts Despite Cochlear Implant Weakness 
Applied Materials Forecasts Strong Q3 Revenue as AI Chip Demand Accelerates 
Nvidia’s China AI Chip Sales Remain Frozen Despite U.S. Approval 
CXMT Forecasts Record Revenue Growth as Global DRAM Prices Surge 
DOJ May Drop Gautam Adani Fraud Charges Amid $10 Billion U.S. Investment Plan 
Samsung Strike Talks Resume as South Korea Weighs Emergency Action 
YouTube and Snap Settle School District Mental Health Lawsuit Ahead of Major Social Media Trial 
Standard Chartered Appoints Manus Costello as New CFO Amid Leadership Reshuffle 
Anthropic Nears $30 Billion Funding Round at $900 Billion Valuation 
Samsung Union Talks Enter Final Stage as Strike Threat Looms 
Thyssenkrupp to Shut Down Indiana Automotive Plant by March 2026 
Honda Shares Jump as Automaker Forecasts Profit Recovery Despite Historic Loss 
TSMC Stake Sale Sends Vanguard Semiconductor Shares Lower 
Amazon Faces Class-Action Lawsuit Over Trump Tariff Price Hikes 
US-China Trade Talks Sideline Chip Export Controls as Nvidia China Sales Draw Attention 
IRVINE, Calif., Sept. 21, 2016 -- Sabra Health Care REIT, Inc. (Nasdaq:SBRA) (Nasdaq:SBRAP) announced today that the company’s management will be participating in a non-deal roadshow hosted by Mizuho Securities USA Inc. on October 5-6, 2016 in Boston, MA and New York, NY.
Sabra Health Care REIT, Inc. (Nasdaq:SBRA) (Nasdaq:SBRAP), a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry. Sabra leases properties to tenants and operators throughout the United States and Canada.
Investor & Media Inquiries: (949) 679-0410
